Localization of Epstein-Barr virus to infiltrating lymphocytes in breast carcinomas and not malignant cells

Experimental and Molecular Pathology

Volumn 91, Issue 1, 2011, Pages 466-470

  Khan, Gulfaraz ^a   Philip, Pretty S ^a   Al Ashari, Mouied ^b   Houcinat, Yamina ^b   Daoud, Sayel ^b  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b TAWAM HOSPITAL   (United Arab Emirates)

Author keywords

Breast cancer; EBV; Emirati; Lymphocytes; Triple negative

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; VIRUS RNA;

ADULT; AGE; AGED; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER CELL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; ETHNIC DIFFERENCE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; LYMPHOCYTIC INFILTRATION; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN EXPRESSION; VIRUS DETECTION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; HERPESVIRUS 4, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; IN SITU HYBRIDIZATION; LYMPHOCYTES, TUMOR-INFILTRATING; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

HUMAN HERPESVIRUS 4;

EID: 79957546246     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2011.04.018     Document Type: Article

References (45)

1. Amarante M.K., Watanabe M.A.E. The possible involvement of virus in breast cancer. J. Cancer Res. Clin. Oncol. 2009, 135:329-337.
2. Anderson W.F., Pfeiffer R.M., Dores G.M., Sherman M.E. Comparison of age distribution patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol. Biomarkers Prev. 2006, 15:1899-1905.
3. Arbach H., Viglasky V., Lefeu F., Guinebretière J.-M., Ramirez V., Bride N., Boualaga N., Bauchet T., Peyrat J.-P., Mathieu M.-C., Mourah S., Podgorniak M.-P., Seignerin J.-M., Takada K., Joab I. Epstein-Barr virus (EBV) genome and expression in breast cancer tissue: effect of EBV infection of breast cancer cells on resistance to paclitaxel (Taxol). J. Virol. 2006, 80:845-853.
4. Arrand J.R., Rymo L. Characterization of the major Epstein-Barr virus-specific RNA in Burkitt lymphoma-derived cells. J. Virol. 1982, 41:376-389.
5. Bonnet M., Guinebretiere J.M., Kremmer E., Grunewald V., Benhamou E., Contesso G., Joab I. Detection of Epstein-Barr virus in invasive breast cancers. J. Natl. Cancer Inst. 1999, 91:1376-1381.
6. Carey L.A., Perou C.M., Livasy C.A., Dressler L.G., Cowan D., Conway K., Karaca G., Troester M.A., Tse C.K., Edmiston S., Deming S.L., Geradts J., Cheang M.C.U., Nielsen T.O., Moorman P.G., Earp H.S., Millikan R.C. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006, 295:2492-2502.
7. Chu P.G., Chang K.L., Chen Y.Y., Chen W.G., Weiss L.M. No significant association of Epstein-Barr virus infection with invasive breast carcinoma. Am. J. Pathol. 2001, 159:571-578.
8. Chun J., Pocock B., Joseph K.-A., El-Tamer M., Klein L., Schnabel F. Breast cancer risk factors in younger and older women. Ann. Surg. Oncol. 2008, 16:96-99.
9. Cox B., Richardson A., Graham P., Gislefoss R.E., Jellum E., Rollag H. Breast cancer, cytomegalovirus and Epstein-Barr virus: a nested case-control study. Br. J. Cancer 2010, 102:1665-1669.
10. Deshpande C.G., Badve S., Kidwai N., Longnecker R. Lack of expression of the Epstein-Barr Virus (EBV) gene products, EBERs, EBNA1, LMP1, and LMP2A, in breast cancer cells. Lab. Invest. 2002, 82:1193-1199.
11. El Saghir N.S., Shamseddine A.I., Geara F., Bikhazi K., Rahal B., Salem Z.M.K., Taher A., Tawil A., El Khatib Z., Abbas J., Hourani M., Seoud M. Age distribution of breast cancer in Lebanon: increased percentages and age adjusted incidence rates of younger-aged groups at presentation. J. Med. Liban. 2002, 50:3-9.
12. El Saghir N.S., Khalil M.K., Eid T., El Kinge A.R., Charafeddine M., Geara F., Seoud M., Shamseddine A.I. Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis. Int. J. Surg. 2007, 5:225-233.
13. Fawzy S., Sallam M., Awad N.M. Detection of Epstein-Barr virus in breast carcinoma in Egyptian women. Clin. Biochem. 2008, 41:486-492.
14. Ferlay J., Parkin D.M., Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur. J. Cancer 2010, 46:765-781.
15. Fina F., Romain S., Ouafik L., Palmari J., Ben Ayed F., Benharkat S., Bonnier P., Spyratos F., Foekens J.A., Rose C., Buisson M., Gérard H., Reymond M.O., Seigneurin J.M., Martin P.M. Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas. Br. J. Cancer 2001, 84:783-790.
16. Glaser S.L., Ambinder R.F., DiGiuseppe J.A., Horn-Ross P.L., Hsu J.L. Absence of Epstein-Barr virus EBER-1 transcripts in an epidemiologically diverse group of breast cancers. Int. J. Cancer 1998, 75:555-558.
17. Glickman J.N., Howe J.G., Steitz J.A. Structural analyses of EBER1 and EBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells. J. Virol. 1988, 62:902-911.
18. Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell 2010, 140:883-899.
19. Hannigan A., Qureshi A.M., Nixon C., Tsimbouri P.M., Jones S., Philbey A.W., Wilson J.B. Lymphocyte deficiency limits Epstein-Barr virus latent membrane protein 1 induced chronic inflammation and carcinogenic pathology in vivo. Mol. Cancer 2011, 10:11.
20. Hemminki K., Mousavi S.M., Sundquist J., Brandt A. Does the breast cancer age at diagnosis differ by ethnicity? A study on immigrants to Sweden. Oncologist 2011, 16:146-154.
21. Hennard C., Pfuhl T., Buettner M., Becker K.-F., Knöfel T., Middeldorp J., Kremmer E., Niedobitek G., Grässer F. The antibody 2B4 directed against the Epstein-Barr virus (EBV)-encoded nuclear antigen 1 (EBNA1) detects MAGE-4: implications for studies on the EBV association of human cancers. J. Pathol. 2006, 209:430-435.
22. Herrmann K., Niedobitek G. Lack of evidence for an association of Epstein-Barr virus infection with breast carcinoma. Breast Cancer Res. 2003, 5:R13-R17.
23. Joshi D., Quadri M., Gangane N., Joshi R., Gangane N. Association of Epstein Barr virus infection (EBV) with breast cancer in rural Indian women. PLoS One 2009, 4:e8180. Jan 6. [Epub ahead of print] DOI:10.1007/s12253-010-9325-z.
24. Kadivar M., Monabati A., Joulaee A., Hosseini N. Epstein-Barr virus and breast cancer: lack of evidence for an association in Iranian women. Pathol. Oncol. Res. 2011.
25. Khan G. Epstein-Barr virus, cytokines, and inflammation: a cocktail for the pathogenesis of Hodgkin's lymphoma?. Exp. Hematol. 2006, 34:399-406.
26. Khan G. Screening for Epstein-Barr virus in Hodgkin's lymphoma. Methods Mol. Biol. 2009, 511:311-322.
27. Khan G., Coates P.J., Kangro H.O., Slavin G. Epstein Barr virus (EBV) encoded small RNAs: targets for detection by in situ hybridisation with oligonucleotide probes. J. Clin. Pathol. 1992, 45:616-620.
28. Khan G., Miyashita E.M., Yang B., Babcock G.J., Thorley-Lawson D.A. Is EBV persistence in vivo a model for B cell homeostasis?. Immunity 1996, 5:173-179.
29. Labrecque L.G., Barnes D.M., Fentiman I.S., Griffin B.E. Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res. 1995, 55:39-45.
30. Magrath I., Bhatia K. Breast cancer: a new epstein-barr virus-associated disease?. J. Natl. Cancer Inst. 1999, 91:1349-1350.
31. Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature 2008, 454:436-444.
32. Mazouni C., Fina F., Romain S., Ouafik L., Bonnier P., Brandone J., Martin P. Epstein-Barr virus as a marker of biological aggressiveness in breast cancer. Br. J. Cancer 2011, 104:332-337.
33. Murray P.G. Epstein-Barr virus in breast cancer: artefact or aetiological agent?. J. Pathol. 2006, 209:427-429.
34. Murray P.G., Lissauer D., Junying J., Davies G., Moore S., Bell A., Timms J., Rowlands D., McConkey C., Reynolds G.M., Ghataura S., England D., Caroll R., Young L.S. Reactivity with A monoclonal antibody to Epstein-Barr virus (EBV) nuclear antigen 1 defines a subset of aggressive breast cancers in the absence of the EBV genome. Cancer Res. 2003, 63:2338-2343.
35. Parise C.A., Bauer K.R., Caggiano V. Variation in breast cancer subtypes with age and race/ethnicity. Crit. Rev. Oncol. Hematol. 2010, 76:44-52.
36. Perrigoue J.G., den Boon J.A., Friedl A., Newton M.A., Ahlquist P., Sugden B. Lack of association between EBV and breast carcinoma. Cancer Epidemiol. Biomarkers Prev. 2005, 14:809-814.
37. Pikarsky E., Porat R.M., Stein I., Abramovitch R., Amit S., Kasem S., Gutkovich-Pyest E., Urieli-Shoval S., Galun E., Ben-Neriah Y. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004, 431:461-466.
38. Podo F., Buydens L.M.C., Degani H., Hilhorst R., Klipp E., Gribbestad I.S., Van Huffel S.W.M., van Laarhoven H., Luts J., Monleon D., Postma G.J., Schneiderhan-Marra N., Santoro F., Wouters H., Russnes H.G., Sørlie T., Tagliabue E., Børresen-Dale A.-L. Triple-negative breast cancer: present challenges and new perspectives. Mol. Oncol. 2010, 4:209-229.
39. Preciado M.V., Chabay P.A., De Matteo E.N., Gonzalez P., Grinstein S., Actis A., Gass H.D. Epstein-Barr virus in breast carcinoma in Argentina. Arch. Pathol. Lab. Med. 2005, 129:377-381.
40. Rickinson A.B., Kieff E. Epstein-Barr virus. Fields Virology 2006, Lippincott Williams & Wilkins, Philadelphia, PA. D.M. Knipe, P.M. Howley (Eds.).
41. Salim E.I., Moore M.A., Al-Lawati J.A., Al-Sayyad J., Bazawir A., Bener A., Corbex M., El-Saghir N., Habib O.S., Maziak W., Mokhtar H.C., Seif-Eldrin I.A.-B., Sobue T. Cancer epidemiology and control in the Arab world - past, present and future. Asian Pac. J. Cancer Prev. 2009, 10:3-16.
42. Thorne L.B., Ryan J.L., Elmore S.H., Glaser S.L., Gulley M.L. Real-time PCR measures Epstein-Barr Virus DNA in archival breast adenocarcinomas. Diagn. Mol. Pathol. 2005, 14:29-33.
43. Tsai J.-H., Tsai C.-H., Cheng M.-H., Lin S.-J., Xu F.-L., Yang C.-C. Association of viral factors with non-familial breast cancer in Taiwan by comparison with non-cancerous, fibroadenoma, and thyroid tumor tissues. J. Med. Virol. 2005, 75:276-281.
44. Veronesi U., Boyle P., Goldhirsch A., Orecchia R., Viale G. Breast cancer. Lancet 2005, 365:1727-1741.
45. Xue S.A., Lampert I.A., Haldane J.S., Bridger J.E., Griffin B.E. Epstein-Barr virus gene expression in human breast cancer: protagonist or passenger?. Br. J. Cancer 2003, 89:113-119.